Cargando…
To Discover the Efficient and Novel Drug Targets in Human Cancers Using CRISPR/Cas Screening and Databases
CRISPR/Cas has emerged as an excelle nt gene-editing technology and is used worldwide for research. The CRISPR library is an ideal tool for identifying essential genes and synthetic lethality targeted for cancer therapies in human cancers. Synthetic lethality is defined as multiple genetic abnormali...
Autores principales: | Onishi, Iichiroh, Yamamoto, Kouhei, Kinowaki, Yuko, Kitagawa, Masanobu, Kurata, Morito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622676/ https://www.ncbi.nlm.nih.gov/pubmed/34830205 http://dx.doi.org/10.3390/ijms222212322 |
Ejemplares similares
-
Efficient Identification of the MYC Regulator with the Use of the CRISPR Library and Context-Matched Database Screenings
por: Tanaka, Yosuke, et al.
Publicado: (2022) -
Bone marrow niches in myeloid neoplasms
por: Kitagawa, Masanobu, et al.
Publicado: (2019) -
CRISPR screening identifies M1AP as a new MYC regulator with a promoter-reporter system
por: Yamamoto, Akiko, et al.
Publicado: (2020) -
Overview of Ferroptosis and Synthetic Lethality Strategies
por: Kinowaki, Yuko, et al.
Publicado: (2021) -
Subcellular localization of MCM2 correlates with the prognosis of ovarian clear cell carcinoma
por: Aihemaiti, Gulinisha, et al.
Publicado: (2018)